{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:08:56Z","timestamp":1792588136808,"version":"4.5.0"},"reference-count":24,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Visceral leishmaniasis (VL) is an endemic zoonotic disease in southern Europe with increasing clinical relevance among immunocompromised populations; however, detailed clinical data remain scarce. This retrospective multicentre cohort study analysed patients with confirmed VL treated at seven hospitals in Greece over a 26-year period. Clinical, treatment, and outcome data were collected with a minimum follow-up of 18 months to assess cure, treatment failure, relapse, and mortality. A total of 144 patients were enrolled (59% male; mean age 41.8 years, range 0.1\u201384 years), most of whom were Greek nationals (85%) and resided in rural areas (61%). Fever was the primary reason for hospital admission in 95% of patients. At diagnosis, 42 patients (29%) were immunocompromised. These patients were significantly older than immunocompetent individuals and more likely to present with diarrhoea and arthralgia, whereas hepatomegaly was less frequent. Liposomal amphotericin B was administered to 90% of patients. Treatment failure occurred in 14 patients (10%) and was significantly associated with immunosuppression and leukaemia. Relapse within 18 months occurred in 5.5% of patients. Overall mortality was relatively low (7 patients, 5%), with one death directly attributable to VL. This study demonstrates that VL remains endemic in Greece, affects patients across all age groups, and is primarily autochthonous. Immunosuppression is associated with distinct clinical features and poorer treatment outcomes in VL, underscoring the need for heightened clinical vigilance, combined diagnostic approaches, and extended follow-up in vulnerable populations.<\/jats:p>","DOI":"10.3390\/pathogens15020141","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T15:04:46Z","timestamp":1769612686000},"page":"141","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical, Laboratory, and Therapeutic Characteristics of Visceral Leishmaniasis with Emphasis on Immune Status: A Multicentre Cohort Study in Greece"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6567-1999","authenticated-orcid":false,"given":"Aristos","family":"Aristodimou","sequence":"first","affiliation":[{"name":"Division of Internal Medicine, School of Medicine, University of Crete, 70013 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achilleas","family":"Gikas","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, School of Medicine, University of Crete, 70013 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Antoniou","sequence":"additional","affiliation":[{"name":"Parasitology and Medical Entomology Unit, School of Medicine, University of Crete, 70013 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4289-9494","authenticated-orcid":false,"given":"Karolina","family":"Akinosoglou","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University General Hospital of Patras, 26504 Rio, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Partalis","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, General Hospital of Chania, 73100 Chania, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelos","family":"Pefanis","sequence":"additional","affiliation":[{"name":"Department of Medicine and 1st Department of Infectious Diseases, General Hospital for Thoracic Diseases \u201cSotiria\u201d, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Periklis","family":"Panagopoulos","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, University General Hospital Alexandroupolis, Democritus University of Thrace, 68100 Alexandroupolis, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2847-6396","authenticated-orcid":false,"given":"Charalambos","family":"Christofidis","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, General Hospital of Volos, 38222 Volos, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9526-3852","authenticated-orcid":false,"given":"Evangelos I.","family":"Kritsotakis","sequence":"additional","affiliation":[{"name":"Laboratory of Biostatistics, School of Medicine, University of Crete, 70013 Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"ref_2","unstructured":"WHO (2018). Surveillance of leishmaniasis in the WHO European Region, 2016 and Global leishmaniasis surveillance update, 1998\u20132016. Wkly. Epidemiol. Record., 93, 521\u2013530."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/CLEP.S44267","article-title":"Epidemiology of Visceral Leishmaniasis","volume":"6","author":"Ready","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jinf.2014.07.016","article-title":"Leishmaniasis","volume":"69","author":"Pace","year":"2014","journal-title":"J. Infect."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"906","DOI":"10.4269\/ajtmh.13-0070","article-title":"Leishmaniases in Greece","volume":"89","author":"Ntais","year":"2013","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/1469-0691.12556","article-title":"Leishmaniasis in immunosuppressed individuals","volume":"20","author":"Carrillo","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijid.2015.02.021","article-title":"Current clinical, laboratory, and treatment outcome characteristics of visceral leishmaniasis: Results from a seven-year retrospective study in Greece","volume":"34","author":"Georgiadou","year":"2015","journal-title":"Int. J. Infect. Dis."},{"key":"ref_8","unstructured":"World Health Organization (2010). Control of the Leishmaniases: Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniases, WHO. WHO Technical Report Series 949."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: What are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Bain, B.J., Clark, D.M., and Wilkins, B.S. (2019). Bone Marrow Pathology, John Wiley & Sons. [5th ed.].","DOI":"10.1002\/9781119398929"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00001432-200212000-00007","article-title":"Advances in the treatment of leishmaniasis","volume":"15","author":"Sundar","year":"2002","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Monge-Maillo, B., Norman, F.F., Cruz, I., Alvar, J., and L\u00f3pez-V\u00e9lez, R. (2014). Visceral Leishmaniasis and HIV Coinfection in the Mediterranean Region. PLoS Neglected. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0003021"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Cota, G.F., de Sousa, M.R., and Rabello, A. (2011). Predictors of Visceral Leishmaniasis Relapse in HIV-Infected Patients: A Systematic Review. PLoS Neglected. Trop. Dis., 5.","DOI":"10.1371\/journal.pntd.0001153"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The Relationship between Leishmaniasis and AIDS: The Second 10 Years","volume":"21","author":"Alvar","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3201\/eid1506.071666","article-title":"Increasing Incidence of Zoonotic Visceral Leishmaniasis on Crete, Greece","volume":"15","author":"Antoniou","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Fletcher, K., Issa, R., and Lockwood, D.N.J. (2015). Visceral Leishmaniasis and Immunocompromise as a Risk Factor for the Development of Visceral Leishmaniasis: A Changing Pattern at The Hospital for Tropical Diseases, London. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0121418"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/1120009X.2017.1323150","article-title":"Visceral leishmaniosis in immunocompromised host: An update and literature review","volume":"29","author":"Pagliano","year":"2017","journal-title":"J. Chemother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jinf.2008.02.013","article-title":"Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis\u2014Case report and systematic review","volume":"56","author":"Rajagopala","year":"2008","journal-title":"J. Infect."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Khamashta","year":"2014","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Cota, G.F., De Sousa, M.R., Demarqui, F.N., and Rabello, A. (2012). The Diagnostic Accuracy of Serologic and Molecular Methods for Detecting Visceral Leishmaniasis in HIV Infected Patients: Meta-Analysis. PLoS Neglected. Trop. Dis., 6.","DOI":"10.1371\/journal.pntd.0001665"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.4269\/ajtmh.16-0940","article-title":"Is Visceral Leishmaniasis Different in Immunocompromised Patients Without Human Immunodeficiency Virus? A Comparative, Multicenter Retrospective Cohort Analysis","volume":"97","author":"Ramos","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cmi.2014.09.002","article-title":"Risk factors, clinical features and outcomes of visceral leishmaniasis in solid-organ transplant recipients: A retrospective multicenter case\u2013control study","volume":"21","author":"Clemente","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1473-3099(08)70043-4","article-title":"Leishmaniasis among organ transplant recipients","volume":"8","author":"Antinori","year":"2008","journal-title":"Lancet Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.micinf.2005.06.002","article-title":"Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature","volume":"7","author":"Basset","year":"2005","journal-title":"Microbes. Infect."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/15\/2\/141\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T15:23:45Z","timestamp":1769613825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/15\/2\/141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["pathogens15020141"],"URL":"https:\/\/doi.org\/10.3390\/pathogens15020141","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]}}}